JPH0246593B2 - - Google Patents

Info

Publication number
JPH0246593B2
JPH0246593B2 JP55029676A JP2967680A JPH0246593B2 JP H0246593 B2 JPH0246593 B2 JP H0246593B2 JP 55029676 A JP55029676 A JP 55029676A JP 2967680 A JP2967680 A JP 2967680A JP H0246593 B2 JPH0246593 B2 JP H0246593B2
Authority
JP
Japan
Prior art keywords
ester
esters
salts
salt
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP55029676A
Other languages
English (en)
Japanese (ja)
Other versions
JPS56125392A (en
Inventor
Ikuo Ueda
Masakazu Kobayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to JP2967680A priority Critical patent/JPS56125392A/ja
Priority to DE8181101456T priority patent/DE3167258D1/de
Priority to EP81101456A priority patent/EP0036510B1/en
Priority to EP83106851A priority patent/EP0096903A3/en
Priority to AT81101456T priority patent/ATE10372T1/de
Priority to US06/240,469 priority patent/US4368325A/en
Publication of JPS56125392A publication Critical patent/JPS56125392A/ja
Publication of JPH0246593B2 publication Critical patent/JPH0246593B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2967680A 1980-03-06 1980-03-06 Cepham and cephem compound and preparation thereof Granted JPS56125392A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2967680A JPS56125392A (en) 1980-03-06 1980-03-06 Cepham and cephem compound and preparation thereof
DE8181101456T DE3167258D1 (en) 1980-03-06 1981-02-28 Synisomer cephalosporin compounds and processes for their preparation
EP81101456A EP0036510B1 (en) 1980-03-06 1981-02-28 Synisomer cephalosporin compounds and processes for their preparation
EP83106851A EP0096903A3 (en) 1980-03-06 1981-02-28 Intermediate compounds for preparing cephem compounds and processes for their preparation
AT81101456T ATE10372T1 (de) 1980-03-06 1981-02-28 Synisomer von cephalosporinverbindungen und verfahren zu ihrer herstellung.
US06/240,469 US4368325A (en) 1980-03-06 1981-03-04 Processes for preparing 3-cephem compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2967680A JPS56125392A (en) 1980-03-06 1980-03-06 Cepham and cephem compound and preparation thereof

Publications (2)

Publication Number Publication Date
JPS56125392A JPS56125392A (en) 1981-10-01
JPH0246593B2 true JPH0246593B2 (en, 2012) 1990-10-16

Family

ID=12282708

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2967680A Granted JPS56125392A (en) 1980-03-06 1980-03-06 Cepham and cephem compound and preparation thereof

Country Status (5)

Country Link
US (1) US4368325A (en, 2012)
EP (2) EP0096903A3 (en, 2012)
JP (1) JPS56125392A (en, 2012)
AT (1) ATE10372T1 (en, 2012)
DE (1) DE3167258D1 (en, 2012)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17188A (en) * 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
JPS57193489A (en) * 1981-05-21 1982-11-27 Fujisawa Pharmaceut Co Ltd Syn-isomer of 7-substituted-3-cephem-4-carboxylic acid ester and its preparation
JPS61171464A (ja) * 1985-01-23 1986-08-02 Dai Ichi Seiyaku Co Ltd オキシイミノ酪酸誘導体の製法
DE3528753A1 (de) * 1985-08-10 1987-02-19 Bayer Ag Substituierte pyrazolin-5-one
US5604222A (en) * 1993-12-27 1997-02-18 Lupin Laboratories, Ltd. Method for the preparation of 2-chloro sulfinyl azetidinones
US5578721A (en) * 1994-07-11 1996-11-26 Lupin Laboratories Limited Process for preparation of 3-exomethylene cepham sulfoxide esters
CN102070560A (zh) * 2010-12-10 2011-05-25 湖北楚阳科技股份有限公司 利用相转移技术生产氨噻肟酸的制备方法
SI3616695T1 (sl) 2011-09-09 2025-01-31 Merck Sharp & Dohme Llc Ceftolozan/tazobaktam za zdravljenje intrapulmonalnih okužb
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
MX387913B (es) 2013-03-15 2025-03-19 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1536281A (en) * 1975-06-09 1978-12-20 Takeda Chemical Industries Ltd Cephem compounds
JPS6011713B2 (ja) * 1976-09-08 1985-03-27 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法
JPS5498795A (en) * 1978-01-13 1979-08-03 Takeda Chem Ind Ltd Cephalosporin derivative and its preparation
EP0048504B1 (en) * 1978-09-12 1988-08-17 Fujisawa Pharmaceutical Co., Ltd. Intermediate compounds for preparing cephem compounds; processes for their preparation and processes for preparing cephem compounds

Also Published As

Publication number Publication date
EP0036510A3 (en) 1981-12-02
EP0096903A3 (en) 1984-02-01
EP0036510B1 (en) 1984-11-21
EP0096903A2 (en) 1983-12-28
ATE10372T1 (de) 1984-12-15
DE3167258D1 (en) 1985-01-03
US4368325A (en) 1983-01-11
EP0036510A2 (en) 1981-09-30
JPS56125392A (en) 1981-10-01

Similar Documents

Publication Publication Date Title
JPH0246593B2 (en, 2012)
EP0007633B1 (en) Cephem compounds, processes for their preparation and pharmaceutical compositions containing them
EP0009671B1 (en) Starting compounds for preparing cephem compounds and processes for their preparation
JPH0149271B2 (en, 2012)
JPS6238357B2 (en, 2012)
JPS6341913B2 (en, 2012)
Gordon et al. Sulfenyl transfer rearrangement of sulfenimines (thiooximes). A novel synthesis of 7. alpha.-methoxycephalosporins and 6. alpha.-methoxypenicillins
JP2005179336A (ja) 1−オキサセファロスポリン−7α−メトキシ−3−クロルメチル誘導体の製法
KR0140887B1 (ko) 7-[2-(2-아미노티아졸-4-일)-2-하이드록시이미노아세타미도]-3-세펨 화합물의 제조방법
JPH0476990B2 (en, 2012)
JPH0830051B2 (ja) 4−ハロゲノ−2−置換オキシイミノ−3−オキソ酪酸のエステルまたはアミドの製造法
JP2003525932A (ja) 新規チアゾール化合物およびその製造方法
KR880001990B1 (ko) 페니실린과 세팔로스포린 화합물의 제조방법 및 이들의 제조에 사용한 새로운 중간체의 제조방법
EP0613480A1 (en) Process for the preparation of cephem derivatives
JP2004149412A (ja) 7−[2−(2−アミノチアゾール−4−イル)−2−低級アルコキシカルボニルメトキシイミノアセトアミド]−3−セフェム化合物の製造法
JPH0355475B2 (en, 2012)
JPH0133106B2 (en, 2012)
US5162522A (en) Method for producing cephem compounds
JPH0244474B2 (ja) Karubasefuemukagobutsu
JPH0354110B2 (en, 2012)
KR810000635B1 (ko) 세팔로스포린 화합물의 제조법
KR900003407B1 (ko) 실릴화합물 및 그 제조방법
JPS5832849A (ja) β−アミノプロピオン酸誘導体の製造法
JPH0321555B2 (en, 2012)
JPS58105993A (ja) 異性体構造を有する新規β−ラクタム誘導体